AXP
63
3
SHW
43
4
WY
37
7
GILD
38
-11
MLM
31
2
TMO
62
3
NAVI
24
2
SYK
48
-2
STT
54
12
XOM
44
7
NRG
35
-7
BAX
36
7
TROW
37
10
ROK
34
2
MOS
59
11
COP
34
-8
HSY
32
-2
PSA
40
2
UNP
43
14
NWS
60
2
AXP
63
3
SHW
43
4
WY
37
7
GILD
38
-11
MLM
31
2
TMO
62
3
NAVI
24
2
SYK
48
-2
STT
54
12
XOM
44
7
NRG
35
-7
BAX
36
7
TROW
37
10
ROK
34
2
MOS
59
11
COP
34
-8
HSY
32
-2
PSA
40
2
UNP
43
14
NWS
60
2
Financhill
Back

Pyxis Oncology 10K Form

Sell
13

PYXS
Pyxis Oncology

Last Price:
$1.43
Seasonality Move:
99.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PYXS News And Ratings

See the #1 stock for the next 7 days that we like better than PYXS

PYXS Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-14.7M
Price / Cash Flow: 0
Annual Sales: $2.59
Price / Book: 0.59

Profitability

EPS (TTM): -1.03000
Net Income (TTM): $-57.4M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Pyxis Oncology Earnings Forecast

Key Pyxis Oncology Financial Ratios

  • Per Share Earnings over the last 5 years have been positive in 2 years.

Pyxis Oncology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PYXS
Website: pyxisoncology.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 12.19
Quick Ratio: 11.67

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PYXS Technical Analysis vs Fundamental Analysis

Sell
13
Pyxis Oncology (PYXS) is a Sell

Is Pyxis Oncology a Buy or a Sell?

  • Pyxis Oncology stock is rated a Sell
    The current Pyxis Oncology [PYXS] share price is $1.53. The Score for PYXS is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.